Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
PHASE2CompletedINTERVENTIONAL
Enrollment
90
Participants
Timeline
Start Date
September 30, 2006
Primary Completion Date
May 31, 2011
Conditions
Prostate Cancer
Interventions
DRUG
etoposide
DRUG
mitoxantrone hydrochloride
DRUG
prednisone
DRUG
vinorelbine tartrate
Trial Locations (1)
14076
Centre Regional Francois Baclesse, Caen
All Listed Sponsors
lead
Groupe D'Etude des Tumeurs Uro-Genitales
OTHER
NCT00627354 - Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | Biotech Hunter | Biotech Hunter